5 Best Revenue Growth Stocks to Buy

Page 5 of 5

1. Axonics, Inc. (NASDAQ:AXNX)

Number of Hedge Fund Investors In Q1 2023: 30

Axonics, Inc. (NASDAQ:AXNX) develops devices that help people with bladder problems. It has consistently grown its revenues over the past five years, which lends it an average growth rate of 363%.

30 of the 943 hedge funds part of Insider Monkey’s database had bought Axonics, Inc. (NASDAQ:AXNX)’s shares as of Q1 2023. Out of these, Steve Cohen’s Point72 Asset Management has the largest stake, since it owns $58 million worth of shares.

Follow Axonics Inc. (NASDAQ:AXNX)

Disclosure: None. You can also take a look at 11 Best CBD Stocks To Buy Now and 11 Most Undervalued Foreign Stocks To Buy.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5